We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
NSIS-B.CO

Price
401.10
Stock movement down
-3.90 (-1.00%)
Company name
Novonesis (Novozymes) A/S
Exchange
(CO
,
Currency
DKK
)
Sector
Basic Materials >
Specialty Chemicals
Market cap
159.47B
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
2.07%
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
24.26
PEG
-
EPS growth
-
1 year return
-13.13%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-31

DIVIDENDS

NSIS-B.CO does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count411.85M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)15.63

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash328.20M
Net receivables704.40M
Total current assets2.05B
Goodwill6.15B
Intangible assets5.05B
Property, plant and equipment0.00
Total assets16.40B
Accounts payable302.10M
Short/Current long term debt0.00
Total current liabilities1.17B
Total liabilities5.66B
Shareholder's equity10.74B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open391.10
Daily high393.00
Daily low386.70
Daily Volume431K
All-time high537.20
1y analyst estimate467.70
Beta0.79
EPS (TTM)-
Dividend per share8.00
Ex-div date21 Aug 2025
Next earnings date25 Feb 2026

Downside potential

Loading...
Downside potential data
NSIS-B.COS&P500
Current price drop from All-time high-25.34%-2.71%
Highest price drop-30.16%-19.00%
Date of highest drop26 Sep 20258 Apr 2025
Avg drop from high-21.58%-2.73%
Avg time to new high-6 days
Max time to new high266 days89 days
COMPANY DETAILS
NSIS-B.CO (Novonesis (Novozymes) A/S) company logo
Marketcap
159.47B
Marketcap category
Large-cap
Description
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, and microbial and medical cleaning services. Further, it offers corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; and fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, wastewater, sewage, and renewable diesel solutions; and agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, enzyme, and biogas solutions. It also provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Lyngby, Denmark.
Employees
10582
Investor relations
-
CEO
Country
Denmark
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The global Food Enzymes market is forecasted to grow from USD 2.33 billion in 2024 to USD 3.93 billion by 2033, at a CAGR of 5.98%. Key growth drivers include increased demand in food processing, enha...
November 24, 2025
Novozymes (CPSE:NSIS B) caught the market’s attention after management raised its 2025 organic sales growth guidance and reported higher sales for both the third quarter and the first nine months of t...
November 12, 2025
On November 6, 2025, Novozymes revised its full-year 2025 earnings guidance upwards and reported financial results for the third quarter and first nine months, with sales reaching €3.16 billion and ne...
November 12, 2025
Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards. COPENHAGEN, Denmark – November 6, 2025. Novonesis delivered 8% organic sales growth...
November 6, 2025
Ester Baiget, President & CEO: ”I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability and cash flow. Our performance was stron...
November 6, 2025
KMDA vs. NVZMY: Which Stock Is the Better Value Option?
October 31, 2025
Noma and Novonesis partner to scale deliciousnessNoma, hailed as one of the world’s best restaurants, is joining forces with Novonesis, the global leader in biosolutions, to take deliciousness to the ...
October 23, 2025
Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of Ambu, as Vice Chair. Lars Rebien Sørensen will step...
October 21, 2025
Manufacturing Day at Novonesis Tue Micheelsen, President, Novonesis North America and Carolyn Lee, President & Executive Director of the Manufacturing Institute accompany students on a Novonesis tour ...
October 6, 2025
Novozymes (CPSE:NSIS B) might not be grabbing headlines with earth-shaking news right now, but that doesn’t mean investors should overlook what’s happening under the surface. Even modest moves can sig...
September 9, 2025
Next page